Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ABT Abbott Laboratories

106,86

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:30:21

Verzögert um 15 Minuten

Morning Brief: Top Financial Stories Dominating on Wednesday, May 25

Reuters

Ford To Pay $19.2M In Multi-State Settlement For False Advertising Claims

Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Click Here for more Abbott Laboratories Charts.

Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Apr 2023 bis Apr 2024

Click Here for more Abbott Laboratories Charts.

News Abbott Laboratories

Abbott Laboratories Reports Strong Q1 Sales Growth Amid Earnings Decline, Raises Full-Year Guidance
Mittwoch 17 April 2024 (1 Woche vor) • IH Market News

Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Mittwoch 17 April 2024 (1 Woche vor) • PR Newswire (US)

US Index Futures See Gains, Oil Prices Dip
Mittwoch 17 April 2024 (1 Woche vor) • IH Market News

Cal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and More
Mittwoch 3 April 2024 (3 Wochen vor) • IH Market News

Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
Dienstag 2 April 2024 (3 Wochen vor) • PR Newswire (US)

Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
Montag 1 April 2024 (4 Wochen vor) • PR Newswire (US)

Abbott Hosts Conference Call for First-Quarter Earnings
Mittwoch 27 März 2024 (4 Wochen vor) • PR Newswire (US)

Une première au Canada -- Abbott fait progresser le traitement de la douleur chronique grâce au plus petit système de stimulation de la moelle épinière implantée et rechargeable au monde
Dienstag 19 März 2024 (1 Monat vor) • PR Newswire (Canada)

Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes
Mittwoch 6 März 2024 (2 Monate vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Abbott Laboratories News-Artikel

Financial Select Sector

Invesco QQQ Trust Series 1

JP Morgan Chase

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen